StockData
TriSalus Life Sciences, Inc. logo

TriSalus Life Sciences, Inc. (TLSI) bonds

TLSINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as TLSIW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$2.45+0.16 (+6.75%)

Close on Nov 18, 2026Market cap $150.86MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$33.07M
Long-term debt
Net debt
-$13.22M
After $46.29M of cash
Implied interest rate
20.11%
FY2025 interest ÷ average debt
Interest coverage
-4.9×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in TriSalus Life Sciences's 10-Q for the period ended Jun 30, 2026

IssueCarrying value
Term Loans$33.07M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
Loan Facility$50.00M–
Loan Facility, December 31, 2025$15.00M–
Loan Facility, Initial Commitment Amount$25.00M$22.08M
Loan Facility, June 30, 2025$10.00M–

See a number that looks wrong?